NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association…
SANTA ANA, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (NKGen), a clinical-stage biotechnology company focused on the development and commercialization of innovative…